Skip to main content
SpringerLink
Log in

Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The literature on the effects of CCK receptor manipulations in animal models of anxiety is rife with inconsistency, and the data subject to a variety of methodological and interpretative difficulties. In the present paper, the effects of a range of CCK receptor ligands on anxiety in male mice have been assessed using an ethological version of the elevated plusmaze test. Compounds selected for study were the agonists, CCK-4 and CCK-8s (12.5–100µg/kg), and the antagonists, devazepide, L-365, 260 and PD 135158 (1.0 µg/kg–1.0mg/kg). CCK-4 failed to produce any significant behavioural effects over the dose range tested, while treatment with the sulphated octapeptide, CCK-8s, induced signs of behavioural inhibition at 100 µ/kg without altering anxiety-related indices. Furthermore, in contrast to the clear anxiolytic profile of diazepam (1 mg/kg), and despite the comprehensive behavioural profiles yielded by ethological analysis, all three CCK receptor antagonists studied (devazepide, L-365, 260 and PD 135158) were found to be without significant effect under present test conditions. Together, present findings provide little support for the involvement of CCK receptor mechanisms in anxiety and, in particular, the form of anxiety evoked in mice by exposure to a plus-maze.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abelson JL, Nesse RM (1994) Pentagastrin infusions in patients with panic disorder. 1.Symptoms and cardiovascular responses. Biol Psychiatry 36:73–83

    Google Scholar 

  • Adamec RE, Shallow T (1993) Lasting effects on rodent anxiety of a single exposure to a cat. Physiol Behav 54:101–109

    Google Scholar 

  • Bickerdike MJ, Marsden CA, Dourish CT, Fletcher A (1994) The influence of 5-hydroxytryptamine reuptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze. Eur J Pharmacol 271:403–411

    Google Scholar 

  • Bradwejn J, Koszycki D, Meterissian G (1990) Cholecystokinintetrapeptide induces panic attacks in patients with panic disorder. Can J Psychiatry 35:83–85

    Google Scholar 

  • Bradwejn J, Koszycki D, Shriqui C (1991) Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder — clinical and behavioral findings. Arch Gen Psychiatry 48:603–610

    Google Scholar 

  • Bradwejn J, Koszycki D, Couetoux du Tertre A, Bourin M, Palmour RM, Ervin FR (1992) The cholecystokinin hypothesis of panic and anxiety disorders: a review. J Psychopharmacol 6:345–351

    Google Scholar 

  • Bradwejn J, Koszycki D, Dutertre AC Vanmegen H, Denboer J, Westenberg H, Annable L (1994) The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch Gen Psychiatry 51:486–493

    Google Scholar 

  • Chopin P, Briley M (1993) The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze. Psychopharmacology 110:409–414

    Google Scholar 

  • Cole JC, Rodgers RJ (1993) An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav Pharmacol 4:573–580

    Google Scholar 

  • Cole JC, Rodgers RJ (1994) Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test — comparison with haloperidol. Psychopharmacology 114:288–296

    Google Scholar 

  • Cole JC, Rodgers RJ (1995) Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze. Pharmacol Biochem Behav 52:473–478

    Google Scholar 

  • Cole, JC, Burroughs, GJ, Laverty, CR, Sherriff, NC, Sparham, EA, Rodgers RJ (1995) Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against α2-adrenoceptor mediation. Psychopharmacology 118:425–436

    Google Scholar 

  • Costall B, Domeney AM, Hughes J, Kelly ME, Naylor RJ, Woodruff GN (1991) Anxiolytic effects of CCK-B antagonists. Neuropeptides 19:65–73

    Google Scholar 

  • Crawley JN, Corwin RL (1994) Biological actions of cholecystokinin. Peptides 15:731–755

    Google Scholar 

  • Cutler NR, Sramek JJ, Kramer MS, Reines SA (1994) Placebo-controlled study of a CCKB antagonist in patents with panic disorder. Biol Psychiatry 35:680

    Google Scholar 

  • Dauge V, Derrien M, Durieux C, Noble F, Corringer PJ, Roques BP (1992) Effects of selective agonists for cholecystokinin receptors CCK-B in nociception and behavior in rodents. Therapie 47:531–539

    Google Scholar 

  • Dawson GR, Rupniak NMJ, Iversen SD, Tricklebank MD (1994) Lack of effect of CCKB receptor antagonists in animal screens for anxiolytic drugs. J Psychopharmacol 8:A47

    Google Scholar 

  • DeMontigny C (1989) Cholecystokinin tetrapeptide induces panic-like attacks in healthy-volunteers — preliminary findings. Arch Gen Psychiatry 46:511–517

    Google Scholar 

  • Derrien M, Durieux C, Dauge V, Roques BP (1993) Involvement of D(2) dopaminergic receptors in the emotional and motivational responses induced by injection of CCK-8 in the posterior part of the rat nucleus-accumbens. Brain Res 617:181–188

    Google Scholar 

  • Derrien M, McCort-Tranchepain I, Ducos B, Roques BP, Durieux C (1994) Heterogeneity of CCK-B receptors involved in animal-models of anxiety. Pharmacol Biochem Behav 49:133–141

    Google Scholar 

  • Dourish CT, Bickerdike MJ, Stanhope KJ, Fletcher A, Marsden CT (1994) Profile of CCKA and CCKB receptor antagonists in the CER end elevated plus-maze models of anxiety in the rat: modulation by 5-HT reuptake blockade. Behav Pharmacol 5:29–30

    Google Scholar 

  • Ervin FR, Palmour RM, Bradwejn J (1991) A new primate model for panic disorder. Biol Psychiatry 29:430S

    Google Scholar 

  • Fink H, Rex A, Marsden CA (1994) Behavioural and neurochemical effects of CCK-fragments in animal models of anxiety. Behav Pharmacol 5:30

    Google Scholar 

  • Harro J, Vasar E (1991a) Cholecystokinin-induced anxiety — how is it reflected in studies on exploratory-behavior? Neurosci Biobehav Rev 15:473–477

    Google Scholar 

  • Harro J, Vasar E (1991b) Evidence that CCKB receptors mediate the regulation of exploratory behavior in the rat. Eur J Pharmacol 193:379–381

    Google Scholar 

  • Harro J, Pold M, Vasar E (1990) Anxiogenic-like action of cerulein, a CCK-8 receptor agonist, in the mouse-influence of acute and subchronic diazepam treatment. Naunyn-Schmiedeberg's Arch Pharmacol 341:62–67

    Google Scholar 

  • Harro J, Vasar E, Bradwejn J (1993) CCK in animal and human research on anxiety. Trends Pharmacol Sci 14:244–249

    Google Scholar 

  • Hays SE, Beinfeld MC, Jensen RT, Goodwin FK, Paul SM (1980) Demonstration of a putative receptor site for cholecystokinin in the rat brain. Neuropeptides 1:53–62

    Google Scholar 

  • Hendrie CA, Dourish CT (1993) Effects of cholecystokinin tetrapeptide (CCK-4) and the CCKB antagonist LY-288513 in a putative model of panic in the mouse. Br J Pharmacol 108:26P

    Google Scholar 

  • Hendrie CA, Neill JC (1992) Ethological analysis of the role of CCK in anxiety. In: Dourish CT, Cooper SJ, Iversen SD, Iversen LL (eds) Multiple cholecystokinin receptors in the CNS. Oxford University Press, Oxford, pp 132–142

    Google Scholar 

  • Hughes J, Boden P, Costall B et al. (1990) Development of a class of selective cholecystokinin type-B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA 87:6728–6732

    Google Scholar 

  • Innis RB, Snyder SH (1980) Cholecystokinin receptor binding in brain and pacreas: regulation of pancreatic binding by cyclic and acyclic guanine nucleotides. Eur J Pharmacol 65:123–124

    Google Scholar 

  • Ivy AC, Goldberg EA (1928) A hormone mechanism for gall bladder contraction and evacuation. Am J Physiol 86:599–613

    Google Scholar 

  • Jensen RT, Lemp GF, Gardner JD (1980) Interaction of cholecystokinin with specific membrane receptors on pancreatic acinae cells. Proc Natl Acad Sci USA 77:2079–2083

    Google Scholar 

  • Jorpes JE, Mutt V (1966) Cholecystokinin and pancreozymin, one single hormone? Acta Physiol Scand 66:196–202

    Google Scholar 

  • Lines C, traub M, Ambrose J (1993) CCK and anxiety in normal volunteers. Neuropsychopharmacology 9:S 181–182

    Google Scholar 

  • Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180–185

    Google Scholar 

  • Mannisto PT, Lang A, Harro J, Peuranen E, Bradwejn J, Vasar E (1994) Opposite effects mediated by CCKA and CCKB receptors in behavioral and hormonal studies in rats. Naunyn-Schmiedeberg's Arch Pharmacol 349:478–484

    Google Scholar 

  • Moran TH, Robinson PH, Goldrich MS, Mchugh PR (1986) 2 brain cholecystokinin receptors — implications for behavioral actions. Brain Res 362:175–179

    Google Scholar 

  • Newman JD, Crepeau LJ (1991) Heart rate changes following administration of putative panicogenic chemicals in squirrel monkeys. Soc Neurosci Abstr 17:420.13

    Google Scholar 

  • Pavlasevic S, Bednar I, Qureshi GA, Sodersten P (1993) Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety. Neuroreport 5:225–228

    Google Scholar 

  • Pellow S, Chopin P, File SE, Briley M (1985) Validation of openclosed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–169

    Google Scholar 

  • Rataud J, Darche F, Piot O, Stutzmann JM, Bohme GA, Blanchard JC (1991) Anxiolytic effect of CCK-Antagonists on plus-maze behavior in mice. Brain Res 548:315–317

    Google Scholar 

  • Ravard S, Dourish CT (1990) Cholecystokinin and anxiety. Trends Pharmacol Sci 11:271–273

    Google Scholar 

  • Ravard S, Dourish CT, Iversen SD (1990) Evidence that the anxiolytic-like effects of the CCK antagonists devazepide and L-365, 260 in the elevated plus-maze paradigm in rats are mediated by CCK receptors. Br J Pharmacol 101:576P

  • Rehfeld JF (1992) CCK and anxiety: introduction. In: Dourish CT, Cooper SJ, Iversen SD, Iversen LL (eds) Multiple cholecystokinin receptors in the CNS. Oxford University Press, Oxford, pp 117–120

    Google Scholar 

  • Rex A, Barth T, Voigt JP, Domeney AM, Fink H (1994a) Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin-octapeptide in rat models of anxiety. Neurosci Lett 172:139–142

    Google Scholar 

  • Rex A, Fink H, Marsden CA (1994b) Effects of BOC-CCK-4 and L365, 260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus-maze. Neuropharmacology 33:559–565

    Google Scholar 

  • Rodgers RJ, Cole JC (1993) Anxitey enhancement in the murine elevated plus-maze by immediate prior exposure to social stressors. Physiol Behav 53:83–388

    Google Scholar 

  • Rodgers RJ, Cole JC (1994a) The elevated plus-maze: pharmacology, methodology and ethology. In: Cooper SJ, Hendrie CA (eds) Ethology and Psychopharmacology. Wiley, Chichester, pp 9–44

    Google Scholar 

  • Rodgers RJ, Cole JC (1994b) Anxiolytic-like effect of (s)-WAY-100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test. Eur J Pharmacol 261:321–325

    Google Scholar 

  • Rodgers RJ, Johnson NJT (1995a) Cholecystokinin and anxiety: promises and pitfalls. Crit Rev Neurobio (in press)

  • Rodgers RJ, Johnson NJT (1995b) Factor analysis of the spatiotemporal and ethological measures in the murine elevated plus-maze. Pharmacol Biochem Behav 52:297–303

    Google Scholar 

  • Rodgers RJ, Shepherd JK (1993) Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology 113:237–242

    Google Scholar 

  • Rodgers RJ, Cole JC, Cobain MR, Daly P, Doran PJ, Eells JR, Wallis P (1992a) Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze — profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP. Behav Pharmacol 3:621–634

    Google Scholar 

  • Rodgers RJ, Lee C, Shepherd JK (1992b) Effects of diazepam on behavioural and antinociceptive responses to the elevated plusmaze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology 106:102–110

    Google Scholar 

  • Rodgers RJ, Cole JC, Davies A (1994a) Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan. Pharmacol Biochem Behav 48:959–963

    Google Scholar 

  • Rodgers RJ, Nikulina EM, Cole JC (1994b) Dopamine D-1 and D-2 receptor ligands modulate the behavior of mice in the elevated plus-maze. Pharmacol Biochem Behav 49:985–995

    Google Scholar 

  • Rodgers RJ, Cole JC, Aboualfa K, Stephenson LH (1995) Ethopharmacological analysis of the effects of putative “anxiogenic” agents in the mouse elevated plus-maze. Pharmacol Biochem Behav 52 (in press)

  • Rupniak NMJ, Schaffer L, Siegl P, Iversen SD (1993) Failure of intravenous pentagastrin challenge to induce panic-like effects in rhesus-monkeys. Neuropeptides 25:115–119

    Google Scholar 

  • Saito A, Goldfine ID, Williams JA (1980) Characterization of receptors for cholecystokinin and related peptides in mouse cerebral cortex. J Neurochem 37:433–490

    Google Scholar 

  • Sauter A, Frick W (1983) Determination of cholecystokinin tetrapeptide and cholecystokinin octapeptide sulfate in different rat-brain regions by high-pressure liquid-chromatography with electrochemical detection. Anal Biochem 133:307–313

    Google Scholar 

  • Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT (1994) Behavioral and pharmacological characterization of the elevated zero-maze as an animal-model of anxiety. Psychopharmacology 116:56–64

    Google Scholar 

  • Singh L, Field MJ, Hughes J, Menzies R, Oles RJ, Vass CA, Woodruff GN (1991a) The behavioral properties of CI-988, a selective cholecystokinin(B) receptor antagonist. Br J Pharmacol 104:239–245

    Google Scholar 

  • Singh L, Lewis AS, Field MJ, Hughes J, Woodruff GN (1991b) Evidence for an involvement of the brain cholecystokinin-B receptor in anxiety. Proc Natl Acad Sci USA 88:1130–1133

    Google Scholar 

  • Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463–469

    Google Scholar 

  • Vanderhaegen JJ, Signeau JC, Gepts W (1975) New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nature 257:604–605

    Google Scholar 

  • Van Megen HJGM, Westenberg HGM, Denboer JA, Haigh JRM, Traub M (1994) Pentagastrin induced panic attacks — enhanced sensitivity in panic disorder patients. Psychopharmacology 114:449–455

    Google Scholar 

  • Vasar E, Peuranen E, Harro J, Lang A, Oreland L, Mannisto PT (1993a) Social-isolation of rats increases the density of cholecystokinin receptors in the frontal-cortex and abolishes the antiexploratory effect of cerulein. Naunyn-Schmiedeberg's Arch Pharmacol 348:96–101

    Google Scholar 

  • Vasar E, Peuranen E, Oopik T, Harro J, Mannisto PT (1993b) Ondansetron, an antagonist of 5-HT3-receptors, antagonizes the antiexploratory effect of cerulein, an agonist of CCK-receptors, in the elevated plus-maze. Psychopharmacology 110:213–218

    Google Scholar 

  • Vasar E, Lang A, Harro J, Bourin M, Bradwejn J (1994) Evidence for potentiation by CCK antagonists of the effect of cholecystokinin-octapeptide in the elevated plus-maze. Neuropharmacology 33:729–735

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ethopharmacology Laboratory, Department of Psychology, University of Leeds, LS2 9JT, Leeds, UK

    N. J. T. Johnson & R. J. Rodgers

Authors
  1. N. J. T. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. J. Rodgers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johnson, N.J.T., Rodgers, R.J. Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice. Psychopharmacology 124, 355–364 (1996). https://doi.org/10.1007/BF02247441

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02247441

Key words

Search

Navigation